Taisho Pharmaceutical's total assets FY 2013-2020
In the fiscal year 2020, Taisho Pharmaceutical Holdings Co., Ltd. held assets valued at approximately 876.92 billion Japanese yen, an increase from around 864.97 billion Japanese yen in the previous fiscal year.
The main products of the Japanese pharmaceutical company include over-the-counter medicines and prescription pharmaceuticals.
The main products of the Japanese pharmaceutical company include over-the-counter medicines and prescription pharmaceuticals.
